203 related articles for article (PubMed ID: 38784980)
1. Kinase inhibitors: 20 years of success and many new challenges and recent trends in their patents.
Aboul-Soud MAM; Al-Sheikh YA; Ghneim HK; Supuran CT; Carta F
Expert Opin Ther Pat; 2024 Jul; 34(7):583-592. PubMed ID: 38784980
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Data-Driven Assessment of Non-Kinase Targets of Inhibitors of the Human Kinome.
Mobasher M; Vogt M; Xerxa E; Bajorath J
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540679
[TBL] [Abstract][Full Text] [Related]
3. Small molecule DNA-PK inhibitors as potential cancer therapy: a patent review (2010-present).
Hu S; Hui Z; Lirussi F; Garrido C; Ye XY; Xie T
Expert Opin Ther Pat; 2021 May; 31(5):435-452. PubMed ID: 33347360
[No Abstract] [Full Text] [Related]
4. Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades.
Imran M; Asdaq SMB; Khan SA; Unnikrishnan Meenakshi D; Alamri AS; Alsanie WF; Alhomrani M; Mohzari Y; Alrashed A; AlMotairi M; Alkhaldi EH; Alorabi AK; Alshrari AS; Tauseef M; Abida ; Alaqel SI; Alam O; Bakht MA
Pharmaceuticals (Basel); 2021 Jul; 14(8):. PubMed ID: 34451807
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 - 2012.
Dymock BW; See CS
Expert Opin Ther Pat; 2013 Apr; 23(4):449-501. PubMed ID: 23367873
[TBL] [Abstract][Full Text] [Related]
6. Kinase inhibitors for CNS diseases: an analysis of the recent patent literature.
Amigoni F; Legnaghi E; Pevarello P
Pharm Pat Anal; 2012 May; 1(2):177-92. PubMed ID: 24236782
[TBL] [Abstract][Full Text] [Related]
7. Systematic Analysis of Covalent and Allosteric Protein Kinase Inhibitors.
Xerxa E; Laufkötter O; Bajorath J
Molecules; 2023 Aug; 28(15):. PubMed ID: 37570774
[TBL] [Abstract][Full Text] [Related]
8. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
9. Dual leucine zipper kinase (MAP3K12) modulators: a patent review (2010-2015).
Oetjen E; Lemcke T
Expert Opin Ther Pat; 2016 May; 26(5):607-16. PubMed ID: 27043251
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in small molecule TBK1 inhibitors: a patent review (2015- 2020).
Thomson DW; Bergamini G
Expert Opin Ther Pat; 2021 Sep; 31(9):785-794. PubMed ID: 33724136
[No Abstract] [Full Text] [Related]
11. c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).
Gehringer M; Muth F; Koch P; Laufer SA
Expert Opin Ther Pat; 2015; 25(8):849-72. PubMed ID: 25991433
[TBL] [Abstract][Full Text] [Related]
12. A patent review of anticancer CDK2 inhibitors (2017-present).
Said MA; Abdelrahman MA; Abourehab MAS; Fares M; Eldehna WM
Expert Opin Ther Pat; 2022 Aug; 32(8):885-898. PubMed ID: 35583393
[TBL] [Abstract][Full Text] [Related]
13. Analysis of patents on anti-rheumatoid arthritis therapies issued in China.
Yuan HY; Zhang XL; Zhang XH; Meng L; Wei JF
Expert Opin Ther Pat; 2015; 25(8):909-30. PubMed ID: 26066366
[TBL] [Abstract][Full Text] [Related]
14. Tropomyosin receptor kinase inhibitors: a patent update 2009 - 2013.
McCarthy C; Walker E
Expert Opin Ther Pat; 2014 Jul; 24(7):731-44. PubMed ID: 24809946
[TBL] [Abstract][Full Text] [Related]
15. Emerging protein kinase inhibitors for the treatment of multiple myeloma.
Lind J; Czernilofsky F; Vallet S; Podar K
Expert Opin Emerg Drugs; 2019 Sep; 24(3):133-152. PubMed ID: 31327278
[No Abstract] [Full Text] [Related]
16. Identification of cellular targets involved in cardiac failure caused by PKI in oncology: an approach combining pharmacovigilance and pharmacodynamics.
Patras de Campaigno E; Bondon-Guitton E; Laurent G; Montastruc F; Montastruc JL; Lapeyre-Mestre M; Despas F
Br J Clin Pharmacol; 2017 Jul; 83(7):1544-1555. PubMed ID: 28098949
[TBL] [Abstract][Full Text] [Related]
17. A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022).
Kovalová M; Baraka JP; Mik V; Jorda R; Luo L; Shao H; Kryštof V
Expert Opin Ther Pat; 2023 Feb; 33(2):67-87. PubMed ID: 36975020
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Pyrazole-based Protein Kinase Inhibitors as Emerging Therapeutic Targets.
Cetin A
Comb Chem High Throughput Screen; 2023 Nov; ():. PubMed ID: 37946345
[TBL] [Abstract][Full Text] [Related]
19. Leucine-rich repeat kinase 2 inhibitors: a review of recent patents (2011 - 2013).
Kethiri RR; Bakthavatchalam R
Expert Opin Ther Pat; 2014 Jul; 24(7):745-57. PubMed ID: 24918198
[TBL] [Abstract][Full Text] [Related]
20. Small-molecule inhibitors of histone deacetylase for the treatment of cancer and non-cancer diseases: a patent review (2011 - 2013).
Valente S; Mai A
Expert Opin Ther Pat; 2014 Apr; 24(4):401-15. PubMed ID: 24397271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
